x

ArriVent BioPharma, Inc. (Nasdaq:AVBP)

Health Care/Life Sciences • Biotechnology
CIK 1868279
Company

Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.

Address
18 Campus Boulevard
Suite 100
Newtown Square, Pennsylvania 19073
Employees
None
Stock Info
Close
$19.82
Day Range
19.58 - 20.45
52 Week Range
14.35 - 25.95
Average volume
79.3K
Short Interest
1.63M (06/28/24)
% of Float Shorted
8.25%
Market Cap
$663.85M
Revenue
N/A
Net Income
-$36.91M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$1.75
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman & Chief Executive Officer
Zheng Bin Yao
Director, President-Research & Development
Stuart Lutzker
Independent Director
Christian W. Nolet
Independent Director
James Irvin Healy
Independent Director
Kristine Peterson
Independent Director
Bahija Jallal
Independent Director
Carl Lee Gordon
Independent Director
John A. Hohneker
SEC filings
DateFormEvent
4 Dec, 2024 SC 13G
14 Nov, 2024 8-K
14 Nov, 2024 SC 13G
14 Nov, 2024 10-Q
12 Nov, 2024 SC 13G
12 Nov, 2024 SC 13G
8 Nov, 2024 SC 13G
24 Oct, 2024 SC 13G
11 Oct, 2024 SC 13G
23 Sep, 2024 4
9 Sep, 2024 8-K
14 Aug, 2024 10-Q
14 Aug, 2024 8-K
9 Jul, 2024 8-K/A
9 Jul, 2024 8-K/A
5 Jun, 2024 8-K
20 May, 2024 3
20 May, 2024 4
16 May, 2024 8-K
8 May, 2024 8-K
8 May, 2024 10-Q
23 Apr, 2024 3
23 Apr, 2024 4
22 Apr, 2024 8-K
28 Mar, 2024 8-K
28 Mar, 2024 10-K
13 Feb, 2024 SC 13G
5 Feb, 2024 SC 13D
2 Feb, 2024 S-8
1 Feb, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
31 Jan, 2024 4
30 Jan, 2024 8-K
29 Jan, 2024 4
29 Jan, 2024 4
26 Jan, 2024 SEC STAFF
26 Jan, 2024 424B4 IPO completed
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 EFFECT
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 3
25 Jan, 2024 CERT
25 Jan, 2024 S-1MEF
23 Jan, 2024 CORRESP
23 Jan, 2024 S-1/A
23 Jan, 2024 8-A12B
23 Jan, 2024 CORRESP
22 Jan, 2024 S-1/A
22 Jan, 2024 CORRESP
12 Jan, 2024 UPLOAD
11 Jan, 2024 CORRESP
5 Jan, 2024 S-1
6 Dec, 2023 DRS/A
5 Dec, 2023 DRSLTR
15 Nov, 2023 UPLOAD
31 Oct, 2023 DRSLTR
31 Oct, 2023 DRS/A
18 Oct, 2023 UPLOAD
13 Oct, 2023 SEC STAFF
4 Oct, 2023 DRSLTR
4 Oct, 2023 DRS/A
27 Sep, 2023 UPLOAD
25 Aug, 2023 DRS
29 Dec, 2022 D
14 Feb, 2022 D/A
23 Jun, 2021 D
Last update:2024-07-17 13:14:44.202234
ArriVent BioPharma, Inc. by TradingView

Sign Up to Subscribe